Dasania 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Lupin Ltd
  4. Dasania 50 mg Tablet

Dasania 50 mg Tablet

Dasania 50 mg Tablet contains dasatinib 50 mg, an oral tyrosine kinase inhibitor used in the treatment of certain blood cancers. It is mainly used for Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The tablet is a prescription medicine and should be used under specialist medical supervision.

BUY NOW

Category

Dasatinib blocks abnormal tyrosine kinase proteins, including BCR-ABL, that promote the growth and survival of leukemia cells. It helps control abnormal white blood cell production in specific Philadelphia chromosome-positive leukemias. Regular blood tests are important because treatment can cause low blood-cell counts and other adverse effects, while some patients may also experience fluid retention or gastrointestinal symptoms. The dose and treatment duration are individualized by the treating hematologist according to the disease and treatment response.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Film-Coated Tablet
Route of Administration Oral
Pack Size 60 Tablets
Manufacturer / Marketer Lupin Ltd

Product Also Known As

Dasania 50mg Tablet, Dasania 50 mg Tablet, Dasania 50 Tablet, Dasatinib 50mg Tablet, Dasatinib 50 mg Tablet, Dasatinib Oral Tablet, Dasatinib Leukemia Tablet